Gf Fund Management Co. Ltd. Ocular Therapeutix, Inc Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 4,026 shares of OCUL stock, worth $29,550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,026
Previous 3,301
21.96%
Holding current value
$29,550
Previous $28.2 Million
4.68%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding OCUL
# of Institutions
207Shares Held
135MCall Options Held
426KPut Options Held
119K-
Deep Track Capital, LP Greenwich, CT14.3MShares$105 Million3.66% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$102 Million98.53% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$93.7 Million22.59% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$84.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.36MShares$61.4 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $565M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...